Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | PPARD | Q03181 | 3/20 | 0.46 |
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | TOP1 | P11387 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1854340 | 1.00 | DGKA (0.51) | DGKATERTPTPN1PPARGPPARD | |
| SCHEMBL29288574 | 1.00 | DGKA (0.51) | DGKATERTPTPN1PPARGPPARD | |
| SCHEMBL3036962 | 0.97 | DGKA (0.51) | DGKATERTPTPN1PPARGPPARD | |
| SCHEMBL17091428 | 0.97 | DGKA (0.51) | DGKATERTPTPN1PPARGPPARD | |
| SCHEMBL10011646 | 0.96 | FAAH (0.52) | DGKAPPARGPPARDPPARAFAAH | |
| SCHEMBL4442370 | 0.91 | FFAR1 (0.61) | DGKATERTPTPN1PPARGPPARD | |
| SCHEMBL290355 | 0.91 | KDM4E (0.44) | USP2LMNADUSP3KMT2AFFAR1 | |
| SCHEMBL3335410 | 0.91 | KDM4E (0.44) | USP2LMNADUSP3KMT2AFFAR1 | |
| SCHEMBL2223196 | 0.91 | KDM4E (0.44) | USP2LMNADUSP3KMT2AFFAR1 | |
| SCHEMBL4611332 | 0.91 | KDM4E (0.44) | USP2LMNADUSP3KMT2AFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104110-A1 | FOAM CONDITIONER | HENKEL AG & CO. KGAA (DE) | 2026-05-21 | — | — | WO | claimed |
| EP-4628299-A1 | POLYOLEFIN-BASED STRETCH FILM | Lotte Chemical Corporation (KR) | 2025-10-08 | — | — | EP | claimed |
| US-12343411-B2 | Compositions and methods for treating keratinous substrates | L'OREAL (FR) | 2025-07-01 | — | — | US | claimed |
| US-12296110-B2 | Hydrophilic medical products and hydration mediums for hydrating the same | HOLLISTER INCORPORATED (US) | 2025-05-13 | — | — | US | claimed |
| US-12291637-B2 | Acidic bonding compositions and methods for restoring and color toning lightened hair | L'OREAL (FR) | 2025-05-06 | — | — | US | claimed |
| WO-2025043394-A1 | KIT FOR FORMING SUPRAMOLECULAR SELF-ASSEMBLY COMPLEX AND USE THEREOF | 北京睿创康泰医药研究院有限公司 | 2025-03-06 | — | — | WO | claimed |
| WO-2025013788-A1 | BREAD CONTAINING SOYBEAN FLOUR AND METHOD FOR PRODUCING SAME | ベースフード株式会社 | 2025-01-16 | — | — | WO | claimed |
| EP-4015008-B1 | PACKAGE CONTAINING HYDROPHILIC URINARY CATHETER AND FOAMED HYDRATION MEDIUM FOR ITS HYDRATION | HOLLISTER INC (US) | 2024-11-13 | — | — | EP | claimed |
| US-20240325273-A1 | COMPOSITION COMPRISING A SPECIFIC COMBINATION OF SURFACTANTS AND A CATIONIC POLYMER | L'OREAL (FR) | 2024-10-03 | — | — | US | claimed |
| EP-4426120-A1 | COMPOSITIONS AND METHODS OF CONTROLLING PESTS | Pertinent Eco-Solutions Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| US-6506391-B1 | Water in oil or oil in water emulsions stabilized with two amphiphilic compounds such as diglyceryl monooleate and n-2-dodecylhexadecyloxycarbonyl-n-methylglucamine which form lamellar and inverse hexagonol phases in presence of water | L'OREAL (FR) | 2003-01-14 | — | — | US | claimed |
| US-20020187174-A1 | Cosmetic or dermatological composition in the form of a dispersion of an oily phase and an aqueos phase, stabilized with cubic gel particles | L'OREAL (FR) | 2002-12-12 | — | — | US | claimed |
| US-20020071820-A1 | Protecting body against the effects of pollution; preferably an aqueous dispersion of 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol, phytanetriol, N-2-alkoxycarbonyl derivatives of N-methylglucamine or monoglycerides | L'OREAL (FR) | 2002-06-13 | — | — | US | claimed |
| EP-0917460-B1 | CYCLOSPORIN FORMULATION | IVAX CR A S (CZ) | 2002-02-27 | — | — | EP | claimed |
| EP-1096255-A2 | Method for measuring skin absorbability | SHISEIDO COMPANY LIMITED (JP) | 2001-05-02 | — | — | EP | claimed |
| EP-0968704-B1 | Cosmetic or dermatological composition | OREAL (FR) | 2000-12-06 | — | — | EP | claimed |
| US-6106860-A | Cyclosporin formulation | GALENA AS (CZ) | 2000-08-22 | — | — | US | claimed |
| EP-0917460-A1 | CYCLOSPORIN FORMULATION | GALENA, A.S. (CZ) | 1999-05-26 | — | — | EP | claimed |
| WO-1998005309-A1 | CYCLOSPORIN FORMULATION | GALENA AS (CZ) | 1998-02-12 | — | — | WO | claimed |
| EP-0661035-B1 | Cosmetic composition for the simultaneous treatment of the superficial skinlayers and the deep skinlayers | OREAL (FR) | 1996-08-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12343411-B2 | Compositions and methods for treating keratinous substrates | KRT18, GK, LIPA | DGKA 26/4885TERT 756/4885PTPN1 4630/4885 |
| US-20240325273-A1 | COMPOSITION COMPRISING A SPECIFIC COMBINATION OF SURFACTANTS AND A CATIONIC POLYMER | KRT18, DSG1, PRKDC | DGKA 589/4885TERT 1374/4885PTPN1 551/4885 |
| US-12291637-B2 | Acidic bonding compositions and methods for restoring and color toning lightened hair | SHH, TIPRL, SMURF1 | DGKA 4198/4885TERT 771/4885PTPN1 2394/4885 |
| US-20020071820-A1 | Protecting body against the effects of pollution; preferably an aqueous dispersion of 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol, phytanetriol, N-2-alkoxycarbonyl derivatives of N-methylglucamine or monoglycerides | KRT18, PLIN3, TK1 | DGKA 45/4885TERT 2789/4885PTPN1 3452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.